Braun-Bostich & Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-7,335
Closed -$187K 116
2020
Q3
$187K Sell
7,335
-7,647
-51% -$203K 0.19% 97
2020
Q2
$388K Hold
14,982
0.38% 50
2020
Q1
$358K Sell
14,982
-8
-0.1% -$252 0.46% 49
2019
Q4
$486K Buy
14,990
+4,485
+43% +$145K 0.48% 43
2019
Q3
$362K Buy
10,505
+1,863
+22% +$62.6K 0.42% 53
2019
Q2
$296K Buy
8,642
+3,547
+70% +$125K 0.31% 65
2019
Q1
$182K Buy
5,095
+4,236
+493% +$144K 0.19% 107
2018
Q4
$28K Buy
859
+293
+52% +$9.37K 0.03% 201
2018
Q3
$18K Buy
+566
New +$17.4K 0.02% 239

Other funds holding EXC

Braun-Bostich & Associates's EXC Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of Exelon (EXC) in Q4 2020, closing a stake of 7,335 shares — an estimated $187K sold.

Braun-Bostich & Associates first reported a position in EXC in Q3 2018 and held it in 9 quarters. The position peaked at $486K in Q4 2019. 919 funds tracked by Wall St. Rank hold EXC as of Q4 2020.

  • Braun-Bostich & Associates reported no remaining Exelon position as of Q4 2020 after selling out during the quarter.
  • Braun-Bostich & Associates sold 7,335 Exelon shares in Q4 2020, an estimated $187K.
  • Braun-Bostich & Associates first reported a position in Exelon in Q3 2018 and held it in 9 quarters.
  • Braun-Bostich & Associates's Exelon position peaked at $486K in Q4 2019.
  • 919 funds tracked by Wall St. Rank held Exelon as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.